Pacific Biosciences Of California | PACB - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $130.15M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Accelerate Diagnostics AXDX:US USD 18.87M 1.94M
Agilent A:US USD 1.33B 4M
Bruker BRKR:US USD 562.6M 14.8M
Danaher DHR:US USD 5.37B 700M
General Electric GE:US USD 14.5B 7.3B
Illumina ILMN:US USD 1.15B 59M
Myriad Genetics MYGN:US USD 233.4M 3.4M
NanoString Technologies NSTG:US USD 76.35M 748K
Pacific Biosciences Of California PACB:US USD 130.15M 15.72M
Quidel QDEL:US USD 746.5M 33.5M
Roche Holding ROG:VX CHF 25.06B 4.31B
Thermo Fisher Scientific TMO:US USD 9.15B 442M
Waters WAT:US USD 510.51M 61.72M